XML 80 R70.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting - Summary of Significant Segment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
REVENUES:            
Total revenues $ 390,657   $ 399,131   $ 697,167 $ 749,503
EXPENSES:            
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below) 49,460   61,472   98,657 120,116
Development programs:            
Alixorexton 23,795   12,589   41,649 23,045
LYBALVI 5,050   3,710   8,901 8,751
Other external R&D expenses 10,589   10,014   21,562 18,803
Total external R&D expenses 39,434   26,313   72,112 50,599
Internal R&D expenses:            
Employee-related 30,651   26,235   62,005 60,780
Occupancy 3,308   2,720   6,455 5,768
Depreciation 1,474   1,375   2,942 2,803
Other internal R&D expenses 2,503   3,006   5,673 7,310
Total internal R&D expenses 37,936   33,336   77,075 76,661
R&D expenses 77,370   59,649   149,187 127,260
Selling, general and administrative expenses:            
Selling and marketing expense 121,175   119,667   244,109 245,284
General and administrative expense 49,674   48,446   98,444 102,578
Total selling, general and administrative expense 170,849   168,113   342,553 347,862
Other segment income (expenses) [1] (5,880)   (15,239)   2,792 (20,659)
NET INCOME FROM CONTINUING OPERATIONS 87,098   94,658   109,562 133,606
LOSS ON DISCONTINUED OPERATIONS, NET OF TAX 0   (3,300)   0 (5,420)
NET INCOME $ 87,098 $ 22,464 $ 91,358 $ 36,828 $ 109,562 $ 128,186
[1] “Other segment income (expenses)” during the three and six months ended June 30, 2025 and 2024, includes “Amortization of acquired intangible assets”, “Other income, net” and “Income tax provision”.